COLLECTION, CRYOPRESERVATION AND SUBSEQUENT VIABILITY OF HEMATOPOIETIC STEM-CELLS INTENDED FOR TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA IN BLAST-CELL TRANSFORMATION
COLLECTION, CRYOPRESERVATION AND SUBSEQUENT VIABILITY OF HEMATOPOIETIC STEM-CELLS INTENDED FOR TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA IN BLAST-CELL TRANSFORMATION
复制标题
DOI:
10.1111/j.1365-2141.1978.tb03656.x
复制
发表时间:
1978-01-01
影响因子:
6.5
通讯作者:
RUUTU, T
中科院分区:
文献类型:
--
作者:
GOLDMAN, JM;THNG, KH;RUUTU, T
Peripheral blood buffy coat (BC) and bone marrow (BM) cells, collected from 47 patients with chronic granulocytic leukemia [CGL] in the chronic phase, were stored at -196.degree. C. Dimethyl sulfoxide (DMSO) 10% was used as cryoprotective agent. As these cells included CFUc [colony-forming units] and probably pluripotential stem cells, they may be transfused as part of the management of patients who enter blast cell transformation. The mean numbers of nucleated cells collected and stored per procedure was about 9 times greater for BC collections than for BM harvests [106 .+-. 49 (SD) .times. 109 vs. 11.9 .+-. 6.6 .times. 109, respectively]. Agar CFUc assay showed that stored cells may remain viable for up to 5 yr. Since in vitro studies showed that CFUc proliferation was not inhibited by low concentrations of DMSO, the removal of all DMSO during cell reconstitution before transfusion may not be necessary. If autologous BC cells are capable of repopulating the BM of patients treated for CGL in blast cell transformation the routine collection and storage of BC rather than BM cells may be desirable for all newly diagnosed patients.